Physician profile
Phyllis Duda
NPI 1235164583
$46,173.87
in general payments reported to CMS, 2019-2025
10 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11K · 2023: $8,834 · 2024: $14K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $10K · Consulting Fee: $7,875 · Food and Beverage: $237 · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,735.77 |
| Travel and Lodging | $10,410.03 |
| Consulting Fee | $7,875.00 |
| Food and Beverage | $237.16 |
| Education | $123.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $45,901.67 | 2022-2025 | |
| Incyte Corporation | $79.99 | 2023 | |
| Merck Sharp & Dohme LLC | $63.04 | 2023-2025 | Lynparza, Welireg, Keytruda |
| Novartis Pharmaceuticals Corporation | $33.45 | 2025 | |
| Array Biopharma INC | $18.87 | 2025 | Mektovi, Braftovi, Tukysa |
| Eisai INC. | $17.44 | 2023 | |
| Genmab U.S., INC. | $16.17 | 2023 | Epkinly |
| Abbvie INC. | $15.43 | 2025 | |
| Lilly USA, LLC | $14.00 | 2024 | Jaypirca, Verzenio |
| Bayer Healthcare Pharmaceuticals INC. | $13.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phyllis Duda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.